Overview

Why care today

5 signals from free data

Analyst target+21.1%Target $157 · 15 analysts

Past 1Y+18.9%1M +15.1% · 3M +17.7%

Strong quality83Top pillar on the scorecard

Institutional103.7%Footprint of total float

Revenue YoY+9.1%Steady but slowing

Where it sits today

52-week price range

Low$108.35

High$160.27

Today $129.84

RSI (14)

56.5Neutral

OversoldHealthyOverbought

Key stats

Market cap$38.25B

P/E (TTM)27.2

EPS next Y+8.8%

Reco score1.48

Avg target$157.27

Implied upside+21.1%

Analysts15

52W high$160.27

52W low$108.35

Div yield79.0%

Beta1.26

Returns

Price action

1 month

+15.1%

3 months

+17.7%

6 months

-9.3%

1 year

+18.9%

Who owns it

Big funds own most of A. Typical for a large U.S. stock.

Fund-owned

>99%

of shares outstanding

Institutions

1,278

reporting holders

Largest holder

Vanguard Group Inc

latest filing

Recent filing moves13F · quarterly

Vanguard Group Inc
Q4 2025 filing
Added0.2%
Blackrock, Inc.
Q1 2026 filing
Added0.1%
Vanguard Capital Management Llc
Q1 2026 filing
Newposition
Vanguard Portfolio Management Llc
Q1 2026 filing
Newposition
State Street Corp
Q1 2026 filing
Added0.7%

Financials

FY TTM

Revenue$7.23B

Rev growth+9.1%

Operating inc.$1.55B

Net income$1.41B

Analyst

Analyst ratings & forecast

BuyTarget $157.27

Based on 15 analysts - 93% rate it a Buy

Implied upside+21.1%Gap to the avg target

Rating mix

Buy 14Hold 1Sell 0

Fundamentals

Fundamentals score

70/ 100

Scores are free · Pro unlocks the call

Composite of valuation, growth, quality & momentum versus sector peers.

Healthcare · Diagnostics & Research

Growth

Momentum

Valuation

Quality

stocksbrew Pro

Know when to buy, hold, or sell A

Scores are above. Pro reads the news on A, flags the catalyst, and gives you one daily call plus the full AI brief.

Daily directive: buy, hold, sell, or watch
Big news and headlines tied to the call
Catalysts, earnings, and risks flagged
Sentiment from news, analysts, and the crowd

3 days free, then $12/mo. Cancel anytime.